TPTakeda PharmaceuticalSee all their emails
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
A real announcement email from Takeda Pharmaceutical. Captured June 15, 2026.
Make this email yours
Migma AI designs one like it with your logo, colors, and images.
About this email
Captured Announcement
Takeda shares a press release regarding new clinical study data for their narcolepsy treatment, Oveporexton.
Top-aligned logo, followed by a branded 'Press Release' hero banner with a molecular graphic. The body features a clear headline, date, and a 'Learn More' CTA. A feedback survey section is included above the footer.
Color palette
Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.